I do rest easier seeing a company I own
continue increasing dividends each year.
Not exact matches
The company
increased its
dividend by 15 percent in 2013 and 8 percent last
year, and said last April that it plans to
continue to raise its
dividend on an annual basis.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full
year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may
increase the amount of discount required on Gilead's products; an
increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay
dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«So our expectation should be that we will
continue to
increase our
dividend and our share buybacks next
year and the
year after that and the
year after that.»
Sam, again this is my opinion, but I think you have done a great job creating a Real estate empire, my empire relies on stocks investing in the greatest
dividend growth companies in the world that have
continued paying
increasing dividends year after
year.
In my experience, a
dividend growth portfolio strategy seems to be performing better as an investment than owning a home, in my honest opinion, I would rather rent in a great area than own a home in that area, jeez if I were able to get a lease agreement for 10
years indexed at inflation or at 2.5 %
increase annually I would take it and take my down payment and invest it in my portfolio, and
continue to contribute the max in my 401K, HSA, and Roth IRA, while enjoying living in a low tax bracket because of my contributions.
If a company has
increased paid
dividends for several
years, it's very likely that it will
continue to do so.
And that big
dividend continues to
increase like clockwork: AT&T has grown its
dividend for 34 consecutive
years.
The company is well positioned to
continue paying its
dividend and offer a modest
increase year after
year.
The remaining criteria are kept under lock and key, but Morningstar suggests that the fund also screens for financial leverage and cash flow metrics to ensure that included companies can
continue to
increase their
dividends year after
year.
01/10/2013 09:31:41 Bought 32 T @ 34.41 Total shares held as of today: 32 Estimated annual
dividend: $ 57.6 Consecutive Dividend Increase: 8 years Dividend yield today: 5.26 % Dividend 5 yr Growth: 5.09 % Dividend Continue r
dividend: $ 57.6 Consecutive
Dividend Increase: 8 years Dividend yield today: 5.26 % Dividend 5 yr Growth: 5.09 % Dividend Continue r
Dividend Increase: 8
years Dividend yield today: 5.26 % Dividend 5 yr Growth: 5.09 % Dividend Continue r
Dividend yield today: 5.26 %
Dividend 5 yr Growth: 5.09 % Dividend Continue r
Dividend 5 yr Growth: 5.09 %
Dividend Continue r
Dividend Continue reading →
Given that United Technologies has made a conscious effort to
increase the
dividend each
year for 23
years straight, I expect them to
continue to do so.
Bottom line: Amgen, Inc. (AMGN) has been rewarding its shareholders with monster
dividend increases for six straight
years, and underlying results warrant a high degree of confidence in this
continuing.
If a company has
increased paid
dividends for several
years, it's very likely that it will
continue to do so.
The company has
increased its
dividend each
year since 2010, and analysts expect a reasonable 80 % AFFO payout ratio next
year, so Public Storage should have no trouble
continuing its
dividend growth streak.
Not only are we comfortable with Pepsi's ability to
continue paying its
dividend we also expect it will
increase the divvy by 7 % per
year for the foreseeable future, which gives
dividend growth investors a nice little kicker.
Your stocks would
continue to pay
increasing dividends year - in - and -
year - out.
They just recently
increased their
dividend by 10 % and with this recent acquisition which almost doubles their market cap, this trend should
continue for
years to come.
Almost every company here has
increased its respective
dividend for many, many
years, and it's likely that they'll
continue to do so.
While they
continue to bring in the profit from their exposure to treatments in oncology and immunology, they also commit themselves to maintaining a strong pipeline of drugs (16 compounds in Phase III trials) that will allow the company to
increase its profit (and thus its
dividend) for many
years to come.
Additionally, I look for companies that have
continued to
increase their
dividend consistently for more than 10
years.
While I wouldn't expect that kind of
dividend growth to
continue on for the foreseeable future, as much of this growth was propelled by a growing payout ratio, the current payout ratio of 45.3 % still leaves a lot of room for
continued dividend increases, even
increases that exceed the rate of underlying profit growth for the next few
years.
It is highly likely the company will
continue to pay
increasing dividends over the next several
years.
Many of these types of companies
continued to raise their
dividends even during the 2008 — 2009 financial crisis, although some were compelled to put
increases on hold for several
years.
Given that Norfolk Southern has made a conscious effort to
increase the
dividend each
year for 15
years straight, I expect them to
continue to do so.
The trend is likely to
continue and they predict
dividend payouts to
increase by 8 % this
year.
Despite commodity price volatility, CN raised its
dividend by 20 % earlier this
year and expects to
continue increasing its
dividend at a faster rate than overall earnings growth.
I am looking forward to them
continuing to
increase their
dividend payout as they have done for the last 12
years to add to my yearly income.
AFL will
continue to
increase its
dividend payout in the upcoming
years and manage their currency exposure.
The key though is that your
dividends continued to
increase month after month and I'm sure made a huge jump
year over
year.
The
dividend was
increased last
year by over 10 % and I am hoping for such returns to
continue in the
years to come.
CMP has 12
years of annual
dividend increases under their belt and I see this trend
continuing in the foreseeable future.
If the
dividend increases continue at this rate I can expect a yield on cost of ~ 4.8 % in 5
years.
In the institutional channel, RFP and related activity
continues to be solid and
increased over last
year, and diversified with interest in MDT and
dividend income for equities and high yield, core broad, low duration for fixed income.
The strong growth and cash flow from Humira, the
continued development of their drug pipeline, and management's commitment to returning capital to shareholders through
dividends has
increased our estimate of fair value for the company and changed our holding period from one
year to multiple
years.
Particularly if a company has a 5 -
year dividend growth rate that is quite high (say > 10 %), understand that it will be difficult or impossible for the company to
continue to
increase its
dividend that fast every
year.
The
dividend payout may
increase over the
years if the company
continues to grow and
increases its profitability.
Meantime, Hormel
continues its streak of annual
dividend increases, which currently stands at 51
years in a row and counting.
In addition, during the past few
years the
dividend has modestly
increased, so hopefully the trend will
continue and its
dividend will grow.
Then in June, the company raised its
dividend by 21 %,
continuing its impressive
dividend increase streak of 46
years.
They've already made good on that with a 10 %
increase earlier this
year; double - digit
dividend growth looks poised to
continue for the foreseeable future.
Assuming I
continue to
increase my
dividends by 8 % per
year my goal should be attainable by the time we look to retire.
I agree that the ROE isn't stellar, averaging 9 % over the past three
years, but I do think the low valuation, strong balance sheet, and most importantly the potential
dividend growth merit your consideration (current
dividend payout is just 32 % of 2013 EPS estimates, and ideally they'd
continue their strong recent series of
increases).
Just because a company has
increased its
dividend for 50
years does not mean it will
continue forever.
Companies that can pay or, even better,
increase their
dividends quarter after quarter and
year after
year are more likely to
continue doing so in the future.
Right now, it isn't clear if the company will
continue to
increase dividends each
year — Praxair has grown
dividends since its spinoff from Union Carbide in 1992 and would be eligible to become a
Dividend Aristocrat at the beginning of 2018.
As such, the YTD total for the percentage
increase will
continue to factor in
year - over-
year increases in stocks» respective
dividends, which will be more accurate than averaging out the quarterly totals.
The Board intends to
continue its approach of considering returning to shareholders any excess of earnings over the sum of ordinary
dividends for the financial
year and
increased capital requirements, normally in the form of special
dividends.
May 2017
continued the trend of
year - over-
year dividend increases for me.
Several companies have records of paying
increasing dividends for 10, 25, or 50 consecutive
years in a row and are still
continuing with this trend.